{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#40 - Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/b4e38ce9\"></iframe>","width":"100%","height":180,"duration":1060,"description":"Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.\nWhat you'll get out of this episode:Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.The need for diverse site participation and data inputs to improve trial accuracy and efficiency.The role of AI and technology in enhancing clinical trial processes.\nTo learn more about our guests and their companies:\nChristine's LinkedIn https://www.linkedin.com/in/christinesenn/\nRohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/\nAdvarra LinkedIn https://www.linkedin.com/company/advarra/\nLokavant LinkedIn https://www.linkedin.com/company/lokavant/\nAdvarra Website https://www.advarra.com/\nLokavant Website https://www.lokavant.com/en-us/\n\nOur sponsor for this episode is:\nSage Growth Partners https://sage-growth.com/\nBioBreakthroughs is part of the Slice of Healthcare podcast network:\nLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}